Hank N is a healthcare-focused commercial leader and former R&D engineer with 10 years of experience bringing complex biologics from lab to market. After engineering roles at Eli Lilly—where he helped develop a purification process for a COVID-19 neutralizing antibody that contributed to an early EUA—he pivoted into oncology marketing via an MBA from Duke Fuqua and now leads KEYTRUDA payer marketing for GU and lung indications at Merck. He combines technical fluency in biologics development with strategic commercialization skills, having launched the KEYTRUDA + Padcev bladder cancer regimen and supported multiple KEYNOTE programs. Colleagues describe him as someone who bridges bench science and market access, intentionally translating technical risk into payer-facing value stories.
10 years of coding experience
4 years of employment as a software developer
Master of Business Administration - MBA, Health Sector Management, Strategy, Master of Business Administration - MBA, Health Sector Management, Strategy at Duke University - The Fuqua School of Business
Bachelor of Science (BS), Chemical Engineering, Bachelor of Science (BS), Chemical Engineering at Michigan State University
Object detection in TensorFlow. Brought to you by Kuprel Industries.
Contributions:1 comment in 18 days
deep-learningobject-detectionindustriestensorflow
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.